Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

1. IMMUNOTHERAPEUTIC SIGNIFICANCE OF NTPASE 8 IN ONCOLOGY

   Ibrohimjon Rahmonovich Asqarov, Irodakhonv Mamatova, Mohinur A. Tadjibaeva

   МақолаAdenosine and Purinergic SignalingJournal of Chemistry of Goods and Traditional Medicine20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.006741

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.002768